767PRESPONSE RATES AND OUTCOMES WITH ENZALUTAMIDE FOR PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER AND VISCERAL DISEASE IN THE PREVAIL TRIAL.
暂无分享，去创建一个
J. Carles | C. Higano | B. Tombal | C. Sternberg | Y. Loriot | S. Chowdhury | T. Beer | J. D. de Bono | J. Alumkal | F. Perabo | H. Mansbach | S. Noonberg | D. Forer